Avicanna’s 4th Medical Symposium – On Demand Session 1: Exploring Cannabinoid-Based Treatments for Epidermolysis Bullosa This session presents a retrospective cohort study from The Hospital for Sick Children on the use of Ultra-Phyto 3% CBD cream in patients with Epidermolysis Bullosa (EB)—a rare group of congenital blistering skin disorders. With limited treatment options beyond supportive care, this research explores the tolerability and potential therapeutic role of topical cannabidiol (CBD) in managing symptoms such as pain and inflammation. What you’ll learn: ✔️ Overview of EB and current treatment gaps ✔️ Study findings on CBD cream use in pediatric EB patients ✔️ Implications for cannabinoid-based dermatological care 🎓 Powered by Avicenna Academy | Presented by Avicanna